NasdaqCM - Delayed Quote USD
Applied DNA Sciences, Inc. (APDN)
At close: November 15 at 4:00 PM EST
Pre-Market: 8:44 AM EST
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Operating Cash Flow
-13,142.0980
-6,217.6770
-8,976.7060
-13,387.9550
-11,143.0590
Investing Cash Flow
-961.3230
-1,095.8080
-489.5530
-2,548.6950
-1,063.6980
Financing Cash Flow
13,789.3170
--
18,126.5960
14,704.8550
19,434.5120
End Cash Position
11,192.1310
7,901.8000
15,215.2850
6,554.9480
7,786.7430
Interest Paid Supplemental Data
--
--
--
--
45.3540
Capital Expenditure
101.0370
-78.4480
-489.5530
-2,548.6950
-1,063.6980
Issuance of Capital Stock
13,788.9230
--
14,426.5210
13,756.5070
10,639.7280
Issuance of Debt
846.7890
--
--
--
846.7890
Repayment of Debt
--
--
--
-1,665.5810
-107.8020
Free Cash Flow
-13,041.0610
-6,296.1250
-9,466.2590
-15,936.6500
-12,206.7570
9/30/2020 - 7/15/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NDRA ENDRA Life Sciences Inc.
4.5400
-14.34%
TTOO T2 Biosystems, Inc.
0.4970
-4.42%
STIM Neuronetics, Inc.
0.7100
-10.13%
PRPH ProPhase Labs, Inc.
0.7500
-0.19%
MYNZ Mainz Biomed N.V.
0.2387
-4.52%
GENE Genetic Technologies Limited
0.7650
0.00%
ISPC iSpecimen Inc.
4.2000
-3.45%
BDSX Biodesix, Inc.
1.3450
-3.93%
PSNL Personalis, Inc.
3.8900
-9.53%
VCYT Veracyte, Inc.
35.94
-2.97%